Molecular Targeted Radiosensitizers: Opportunities and Challenges

Molecular Targeted Radiosensitizers

Opportunities and Challenges
 
Edition number: 1st ed. 2020
Publisher: Humana
Date of Publication:
Number of Volumes: 1 pieces, Book
 
Normal price:

Publisher's listprice:
EUR 160.49
Estimated price in HUF:
66 226 HUF (63 072 HUF + 5% VAT)
Why estimated?
 
Your price:

60 928 (58 026 HUF + 5% VAT )
discount is: 8% (approx 5 298 HUF off)
The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
Click here to subscribe.
 
Availability:

Uncertain availability. Please turn to our customer service.
Can't you provide more accurate information?
 
 
 
 
 
Product details:

ISBN13:9783030497002
ISBN10:3030497003
Binding:Hardback
No. of pages:364 pages
Size:235x155 mm
Weight:729 g
Language:English
Illustrations: 4 Illustrations, black & white; 38 Illustrations, color
0
Category:
Short description:

Molecular Targeted Radiosensitizers: Opportunities and Challenges provides the reader with a comprehensive review of key pre-clinical research components required to identify effective radiosensitizing drugs. The book features discussions on the mechanisms and markers of clinical radioresistance, pre-clinical screening of targeted radiosensitizers, 3D radiation biology for studying radiosensitizers, in vivo determinations of local tumor control, genetically engineered mouse models for studying radiosensitizers, targeting the DNA damage response for radiosensitization, targeting tumor metabolism to overcome radioresistance, radiosensitizers in the era of immuno-oncology, and more. Additionally, the book features discussions on high-throughput drug screening, predictive biomarkers, pre-clinical tumor models, and the influence of the tumor microenvironment and the immune system, with a specific focus on the challenges radiation oncologists and medical oncologists currently face in testing radiosensitizers in human cancers.

Edited by two acclaimed experts in radiation biology and radiosensitizers, with thirteen chapters contributed by experts, this new volume presents an in-depth look at current developments within a rapidly moving field, with a look at where the field will be heading and providing comprehensive insight into the framework of targeted radiosensitzer development. Essential reading for investigators in cancer research and radiation biology.

Long description:

Molecular Targeted Radiosensitizers: Opportunities and Challenges provides the reader with a comprehensive review of key pre-clinical research components required to identify effective radiosensitizing drugs. The book features discussions on the mechanisms and markers of clinical radioresistance, pre-clinical screening of targeted radiosensitizers, 3D radiation biology for studying radiosensitizers, in vivo determinations of local tumor control, genetically engineered mouse models for studying radiosensitizers, targeting the DNA damage response for radiosensitization, targeting tumor metabolism to overcome radioresistance, radiosensitizers in the era of immuno-oncology, and more. Additionally, the book features discussions on high-throughput drug screening, predictive biomarkers, pre-clinical tumor models, and the influence of the tumor microenvironment and the immune system, with a specific focus on the challenges radiation oncologists and medical oncologists currently face in testing radiosensitizers in human cancers.

Edited by two acclaimed experts in radiation biology and radiosensitizers, with thirteen chapters contributed by experts, this new volume presents an in-depth look at current developments within a rapidly moving field, with a look at where the field will be heading and providing comprehensive insight into the framework of targeted radiosensitzer development. Essential reading for investigators in cancer research and radiation biology.

Table of Contents:

 



  1. Introduction
  2. Translating targeted radiosensitizers into the clinic [include focus on normal tissue toxicity
  3. Mechanisms and markers of clinical radioresistance
  4. Pre
    -clinical screening of targeted radiosensitizers
  5. 3D radiation biology for studying radiosensitizers
  6. In vivo determinations of local tumor control and radiosensitzers
  7. GEMMs for studying radiosensitizers
  8. Pre
    -clinical models for studying radioresistance of GBM [include focus on PD/PK]
  9. Targeting the DNA damage response for radiosensitization [include focus on scheduling]
  10. Targeting metabolomics to overcome radioresistance
  11. Targeting cancer stem cells to overcome radioresistance
  12. Genomic biomarkers of radiation response
  13. Targeting the microenvironment
  14. Radiosensitizers in the era of immuno
    -oncology